BeloorBayir Biotech Receives Rs. 75 Crore From India Agri Business Fund

BANGALORE, April 24, 2014 /PRNewswire/ --

BBTL Sets up Aggressive Plans on Production and Market Expansion, Plans to Open Research Centre in USA 

BeloorBayir Biotech Ltd. (BBTL), a leading manufacturer of food and dietary supplements, botanical extracts and nutraceuticals in bulk and finished formulations, today announced the completion of the first round of investment of Rs.75 crore by India Agribusiness Fund Ltd. - Asia's first private equity fund focused on the Indian food and agribusiness sector. BBTL is a part of the Bairy group of companies.

The investment will empower BBTL to further expand its manufacturing capacities across 4 of its 8 plants and will boost other infrastructural abilities. Further, the new funds will be used to strengthen its marketing activities in global regulated markets to fuel future growth.

BBTL is aiming to capitalize on the rapidly expanding supplements market, both domestically and internationally.

Commenting over the funds, Mr. B.G. Bairy, Managing Director and CEO, BBTL said, "We have been growing strong in the pharmaceuticals segment over the years and have established ourselves globally with most of our revenue coming in from USA, South-East Asia, EU and SAARC countries. With the recent funding, we'll not only be focusing to strengthen and increase production capacity, but also focus on the nutracueticals segment globally."

Ajay Bair, Director, BBTL said, "We think nutraceuticals is a high growth, high potential sector and yet not fully developed in India. With this fund in place, we aim to expand research and development capacity and our presence in foreign markets."

BBTL is considering to open a new research and development facility in USA in the post-funding phase.

Spread across a large area, BBTL boasts of world class manufacturing facilities at all its 8 facilities located in and around Bangalore and is administered by a highly-experienced, innovative team of professionals who are dedicated to the ideology of excellent human health and well-being. BBTL is technologically advanced with the latest production and packaging equipment. With a high volume production capacity per day, the facility is the most unique and advanced of its kind in the whole of South East Asia. Using in-house R&D and manufacturing capabilities, BBTL in its formulation wing is focused on providing innovative formulations that offer quality and affordability to consumers.

Mr. Rajesh Srivastava, Chairman and Managing Director of Rabo Equity Advisors, will join the Board of BBTL and support the company in its aggressive growth plans.

"We are excited about the opportunity to support BBTL's management in expanding infrastructure and facilities and also their in-depth research and development around the many uses of food and dietary supplements for better health," Mr. Srivastava said.

"BBTL has built a strong reputation globally for offering the highest quality Nutraceutical-based solutions to both industry and the consumer alike. It is a privilege to support this mission as nutraceuticals is an important focus area for us," Mr. Srivastava added.

Adding to it, Mr. Bairy said, "The opportunity to build upon a great legacy brand with a firm dedication to research, development and clinical science in the field of food and nutraceuticals is very exciting to me, and one in which our customer base will benefit greatly with new innovative and efficacious products."

Citadel Management Consulting Private Limited acted as the exclusive advisor on this deal.

About BBTL 

BBTL produces the wide range finest nutritional supplements and adhere to industry standards. BBTL is a fast-growing, global food sector-focussed, fully integrated food and dietary supplement manufacturing company and a leader in the development, manufacturing and marketing of a range of specialty and super-specialty products encompassing the full life cycle quality control of the product. BBTL is an ISO 9001:2008 certified company where all its manufacturing units meet GMP regulatory requirements of various national and international FDAs and meet all food safety management requirements as an organization that largely falls in the food value chain. BBTL facility is GMP certified and has been registered with the USFDA Registrar's Corporation.

About India Agribusiness Fund Ltd. 

India Agribusiness Fund Ltd. is the first private equity fund focused on the Indian food and agribusiness sector. Conceptualized and sponsored by Rabobank, the fund has a committed capital of USD 120 million. Besides the fund sponsor Rabobank, other investors include premiere institutions such as IFC (part of the World Bank Group), DEG (member of KfW Group and owned 100% by the Government of Germany), FMO (a Dutch development institution owned by the Dutch Government), CDC (a UK-based development institution owned by the British Government) and some premiere private institutional investors such as Capvent. The fund was launched in November 2008. www.bayirextracts.com

Rabo Equity Advisors Private Limited, with offices in New Delhi and Mumbai, is the investment advisor to the fund in identifying and evaluating potential investment opportunities, providing economic and market intelligence to portfolio investments and creating liquidity events for its investors including exit opportunities.

Primary Media Contact : Dhanya Nambiar, Account Executive, PRHUB, +91-9743770732, [email protected] 

Secondary Media Contact : Avishek Rakshit, Account Manager, +91-80-22483007/8, Ext 205, [email protected]